On Hims & Hers Q4 earnings conference call, the company said it may have a “temporary pause in year-over-year margin expansion” due to investments starting in Q4 and continuing through 2026 that are designed to scale new categories, build a larger presence in new markets, and driving greater value to subscribers through partnerships.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
- HIMS Earnings: Hims & Hers Health Reports Mixed Financial Results
- Hims & Hers reports Q3 EPS 6c, consensus 10c
- Hims & Hers sees Q4 revenue $605M-$625M, consensus $629.6M
- Hims & Hers sees FY25 revenue $2.335B-$2.355B, consensus $2.34B
- Hims and Hers Health options imply 12.6% move in share price post-earnings